TI
ACET icon

Trexquant Investment’s Adicet Bio ACET Stock Holding History

Trexquant Investment’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$674K Buy
78,002
+34,336
+79% +$271K ﹤0.01% 1570
2026
Q1 		$297K Buy
+43,666
New +$327K ﹤0.01% 1598
2023
Q3 		– Sell
-6,330
Closed -$246K – 1414
2023
Q2 		$246K Buy
6,330
+5,640
+817% +$498K 0.01% 1252
2023
Q1 		$63.6K Buy
+690
New +$86.6K ﹤0.01% 1391
2022
Q3 		– Sell
-685
Closed -$160K – 1310
2022
Q2 		$160K Buy
+685
New +$150K 0.01% 1400

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Trexquant Investment's ACET Position: Q2 2026 in Review

Trexquant Investment increased its Adicet Bio (ACET) stake by 79% in Q2 2026, buying an estimated $271K and bringing the position to 78,002 shares worth $674K. The position accounts for ﹤0.01% of the portfolio, ranked #1570.

Trexquant Investment first reported a position in ACET in Q2 2022 and has held it in 5 quarters since. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • Trexquant Investment held 78,002 shares of Adicet Bio worth $674K as of Q2 2026.
  • Trexquant Investment bought 34,336 Adicet Bio shares in Q2 2026, an estimated $271K.
  • Adicet Bio made up ﹤0.01% of Trexquant Investment's portfolio in Q2 2026, its #1570 holding.
  • Trexquant Investment first reported a position in Adicet Bio in Q2 2022 and has held it in 5 quarters since.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.